📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Inositec

1.1 - Company Overview

Inositec Logo

Inositec

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of treatments for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs, with lead programs targeting vascular and renal calcification, including orphan indications; founded in 2015 as a spin-off of ETH Zurich.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Inositec

Cytovale Logo

Cytovale

HQ: United States Website
  • Description: Provider of early detection diagnostic technologies for immune-mediated diseases, including the IntelliSep Test for rapid sepsis identification with results in under 10 minutes to aid emergency department triage, powered by microfluidics, precision imaging, and machine learning to analyze complex biological data and perform detailed cellular analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cytovale company profile →
MorphoChem Logo

MorphoChem

HQ: Germany Website
  • Description: Provider of innovative intravenous therapy for Clostridium difficile infection (CDI), based on novel antibacterial MCB3681, addressing an unmet medical need and aiming to make a difference for CDI patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MorphoChem company profile →
LigoCyte Pharmaceuticals Logo

LigoCyte Pharmaceuticals

HQ: United States Website
  • Description: Provider of vaccines and monoclonal antibodies for gastrointestinal and respiratory indications, developing novel immunomodulatory drug compounds that modify immune responses by targeting cell binding interactions for the treatment of inflammatory and infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LigoCyte Pharmaceuticals company profile →
Normax Biomed Logo

Normax Biomed

HQ: Ireland Website
  • Description: Provider of mRNA vaccine R&D and manufacturing for infectious diseases such as tuberculosis and HIV. Delivers Vax Factory, a modular solution for rapid, scalable production; leads the mRNA UCV Consortium; and runs GOAL 2050 to end TB and HIV transmission via mRNA vaccines, affordable treatments, and education, supporting the SDG for good health & well being.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Normax Biomed company profile →
MedMira Logo

MedMira

HQ: Canada Website
  • Description: Provider of rapid diagnostics, including FDA-approved Reveal G4 for instant HIV results using Rapid Vertical Flow Technology; Multiplo Multiplex Tests for simultaneous detection of HIV-1/2, hepatitis B and C, and syphilis; Reveal HIV; Multiplo TP/HIV; Multiplo HBc/HIV/HCV; and the Miriad RVF Toolkit for developing and commercializing rapid tests.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MedMira company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Inositec

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Inositec

2.2 - Growth funds investing in similar companies to Inositec

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Inositec

4.2 - Public trading comparable groups for Inositec

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Inositec

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Inositec

What does Inositec do?

Inositec is a provider of treatments for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs, with lead programs targeting vascular and renal calcification, including orphan indications; founded in 2015 as a spin-off of ETH Zurich.

Who are Inositec's competitors?

Inositec's competitors and similar companies include Cytovale, MorphoChem, LigoCyte Pharmaceuticals, Normax Biomed, and MedMira.

Where is Inositec headquartered?

Inositec is headquartered in Switzerland.

How many employees does Inositec have?

Inositec has 1,000 employees 🔒.

When was Inositec founded?

Inositec was founded in 2010 🔒.

What sector and industry vertical is Inositec in?

Inositec is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Inositec

Who are the top strategic acquirers in Inositec's sector and industry

Top strategic M&A buyers and acquirers in Inositec's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Inositec?

Top strategic M&A buyers groups and sectors for Inositec include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Inositec's sector and industry vertical

Which are the top PE firms investing in Inositec's sector and industry vertical?

Top PE firms investing in Inositec's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Inositec's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Inositec's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Inositec's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Inositec include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Inositec's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Inositec?

The key public trading comparables and valuation benchmarks for Inositec include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Inositec for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Inositec with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Inositec's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Inositec with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Inositec's' sector and industry vertical?

Access recent funding rounds and capital raises in Inositec's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Inositec